| __timestamp | ADMA Biologics, Inc. | BeiGene, Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 21862000 |
| Thursday, January 1, 2015 | 7015946 | 58250000000 |
| Friday, January 1, 2016 | 7688238 | 98033000 |
| Sunday, January 1, 2017 | 6229587 | 269018000 |
| Monday, January 1, 2018 | 3926120 | 679005000 |
| Tuesday, January 1, 2019 | 2343848 | 927338000 |
| Wednesday, January 1, 2020 | 5907013 | 1294877000 |
| Friday, January 1, 2021 | 3646060 | 1459239000 |
| Saturday, January 1, 2022 | 3613764 | 1640508000 |
| Sunday, January 1, 2023 | 3300000 | 1778594000 |
In pursuit of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, BeiGene, Ltd. and ADMA Biologics, Inc. have showcased contrasting trajectories in their R&D investments.
BeiGene, a leader in the field, has consistently ramped up its R&D spending, with a staggering increase of over 8,000% from 2014 to 2023. This surge underscores BeiGene's aggressive pursuit of groundbreaking therapies. In contrast, ADMA Biologics has maintained a more modest R&D budget, peaking in 2014 and gradually declining by approximately 65% by 2023.
This divergence highlights BeiGene's strategic focus on expanding its research capabilities, while ADMA Biologics appears to be optimizing its resources. As the biotech landscape evolves, these spending patterns may well dictate the future success and innovation potential of these two companies.
Research and Development: Comparing Key Metrics for Eli Lilly and Company and BeiGene, Ltd.
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and ADMA Biologics, Inc.
BeiGene, Ltd. vs Incyte Corporation: Strategic Focus on R&D Spending
R&D Spending Showdown: BeiGene, Ltd. vs MorphoSys AG
R&D Insights: How BeiGene, Ltd. and MannKind Corporation Allocate Funds
BeiGene, Ltd. vs Dynavax Technologies Corporation: Strategic Focus on R&D Spending
R&D Insights: How Bio-Techne Corporation and ADMA Biologics, Inc. Allocate Funds
BioMarin Pharmaceutical Inc. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Madrigal Pharmaceuticals, Inc. and ADMA Biologics, Inc. Allocate Funds
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Research and Development Investment: Alkermes plc vs ADMA Biologics, Inc.
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.